response and discusses the use of pharmacological interventions targeting inflammation following infarction. Therapy with broad anti ‐inflammatory and immunomodulatory agents may also inhibit important repair ...
selective inhibition of adhesion molecules targeting the gut to avoid broad suppression of surveillance for JC virus, the causal pathogen of PML. Subsequently, vedolizumab, a humanized anti -α4β7 integrin ...
ex vivo to express ligands of adhesion molecules and acquire the potential to be recruited to the inflamed site, and they were adenovirally transfected with a therapeutic gene followed by transfusion ...